Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics-Reference-Cited by-同舟云学术

Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics

Published:2020-06-16 Issue:7 Volume:22 Page:
ISSN:1523-3774
Container-title:Current Rheumatology Reports
language:en
Short-container-title:Curr Rheumatol Rep

Author:

Melki Isabelle,Frémond Marie-Louise

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s11926-020-00909-4.pdf

Reference134 articles.

1. Isaacs A, Lindenmann J, Valentine RC. Pillars article: virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 268-273. J Immunol. 2015;195:1921–6.

2. Hartmann G. Nucleic acid immunity. Adv Immunol. 2017;133:121–69.

3. Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91–8.

4. Crow YJ. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr Opin Immunol. 2015;32:7–12.

5. Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213:2527–38.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferonopathies: From concept to clinical practice;Best Practice & Research Clinical Rheumatology;2024-08

2. Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score;Lupus;2024-02-05

3. Atteinte pulmonaire dans les maladies auto-inflammatoires;Revue des Maladies Respiratoires;2024-01

4. Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report;Frontiers in Immunology;2023-12-06

5. Ruxolitinib altered IFN-β induced necroptosis of human dental pulp stem cells during osteoblast differentiation;Archives of Oral Biology;2023-11